Will Magioncalda is an associate in the firm’s Business Law Department and a member of its Technology and Life Sciences groups.

Mr. Magioncalda represents clients across the life sciences and technology industries, which include global investment banks as well as public and private companies.

His work extends to every stage of the corporate life cycle from financing through successful initial public offering or acquisition, with a focus on public and private capital markets transactions such as IPOs, follow-on offerings and private placements of equity and debt securities. He also counsels clients on a wide array of corporate matters including mergers and acquisitions, securities law compliance, and corporate governance.





A selection of Mr. Magioncalda’s recent representations include:

Initial Public Offerings and Follow-on Offerings

  • The underwriters in Royalty Pharma plc’s $2.5 billion initial public offering
  • Moderna, Inc. in its $1.34 billion and $500 million public follow-on offering
  • The underwriters in Repare Therapeutics, Inc.’s $253 million initial public offering
  • HOOKIPA Pharma, Inc. in its $84 million initial public offering
  • Goldman Sachs & Co. and other underwriters in Arvinas, Inc.’s $120 million initial public offering and $150 million follow-on offering
  • The underwriters in Immunomedics, Inc.’s $420 million and $285 million public follow-on offerings
  • The underwriters in Krystal Biotech, Inc.’s $125 million public follow-on offering
  • The underwriters in Centogene N.V.’s $56 million initial public offering

Other Corporate Transactions

  • Foundation Medicine, Inc. in connection with its merger with Roche at an enterprise valuation of $5.3 billion
  • Cowen as sales agent in ATM facilities for Albireo Pharma, Ovid Therapeutics and Dynavax Technologies
  • Piper Sandler as sales agent in multiple ATM facilities
  • Akili Interactive Labs, Inc. in its $55 million Series C financing
  • Even Financial, Inc. in its $25 million Series B financing and $18 million Series A financing
  • Aircall.io, Inc. in its $29 million Series B financing
Professional Experience

Prior to joining Goodwin, Mr. Magioncalda was an associate at Cravath, Swaine & Moore LLP in New York.

In The News









J.D., 2015
University of Virginia School of Law
B.S.F.S., 2010
Georgetown University



New York
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique